Evaluating the impact of the Inflation Reduction Act (IRA) will require real-time data and effective therapy metrics, ...

Following results from their new retrospective study, the researchers suggested that immediate reconstruction of the nose ...

Raymond Osarogiagbon, MD, discusses the challenges of implementing lung cancer screening guidelines and the need for increased awareness and access.

Early actions by the new administration signal major changes in health policy, taxes, and pharmaceutical pricing.

Medicaid beneficiaries face higher rates of pulmonary hypertension, with significant economic burdens and racial disparities in prevalence and costs.

Combining immunotherapy with chemotherapy shows promise in enhancing survival rates for extensive-stage small cell lung ...

With artificial intelligence (AI) capabilities freeing up workers and driving billions in gains, pharmacy may soon see a 75% ...

Prior studies have shown that women may absorb cancer therapies differently than men, but this study focused on the fallout ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

Kimlin Tam Ashing, PhD, of City of Hope National Medical Center, emphasizes the vital role of community engagement in cancer research, enhancing trust and communication between scientists and ...

Smoking prevalence is projected to decline by 2035, yet health consequences persist due to slower reductions among older ...

Zongertinib shows promise for treating HER2-mutant non–small cell lung cancer (NSCLC), with significant activity against brain metastases and low interstitial lung disease risk, explains John Heymach, ...